The Role of Resistant Starch in COVID-19 Infection
What is the purpose of this trial?
This study is a multicenter randomized trial to evaluate the efficacy of administering a dietary supplement containing resistant starch to non-hospitalized COVID-19 positive subjects, The intervention will begin as soon as possible after subjects test positive for COVID-19 and continue for 14 days. Investigators hypothesize that short-term administration of a dietary supplement containing resistant starch has the potential to reduce rates of hospitalization and improve time to clinical recovery and symptoms in non-hospitalized COVID-19 positive patients.
- Ages19 years and older
- Trial withPending
- Start Date05/28/2020
- End Date04/30/2021
- Last Updated06/02/2020
- Study HIC#2000027887